K-numberK251308
Device nameSnugLit(TM) Wearable Phototherapy System (SNGL-01-US)
ApplicantThera B Medical Products
Product codeLBI
Device classClass II
Decision dateJan 15, 2026
DecisionSubstantially Equivalent
Regulation880.5700
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The SnugLit Wearable Phototherapy System is a neonatal phototherapy device that delivers therapeutic blue light to infants via a Light Mat enclosed in a Disposable Swaddle. It treats infant hyperbilirubinemia (neonatal jaundice) and can be used in hospitals or homes by licensed medical practitioners or caregivers under supervision. The device is designed for infants weighing 1.5–5.5 kg and measuring 40.5–57.5 cm in length.

Technological characteristics

Both the SnugLit and predicate BiliTouch use blue LED light at similar wavelengths (SnugLit 459–480 nm vs. BiliTouch 455–465 nm) to treat hyperbilirubinemia. The SnugLit provides a larger illuminated area (1080 cm² vs. 420 cm²) to maximize body surface coverage. Both include a control box with LCD display, rechargeable battery, light-emitting pad, disposable cover, and power adapter. The SnugLit offers more precise treatment-time monitoring via a run-time counter displayed in hours:minutes:seconds.

Test standards cited

ISO 10993 series (biocompatibility: cytotoxicity, skin sensitization, irritation); IEC 60601-1, IEC 60601-1-2, IEC 60601-1-8, IEC 60601-1-11, IEC 60601-2-50 (electrical safety and phototherapy basics); IEC 62471 (photobiological safety); IEC 62304 (software validation); ASTM D4169 (transit testing); and FDA's Human Factors guidance (February 2016).

Substantial equivalence argument

The SnugLit is substantially equivalent to the BiliTouch because both devices treat hyperbilirubinemia using blue LED light on the same operating principle, target identical patient populations (infants with neonatal jaundice in hospital or home settings), operate within the same electrical safety standards, and deliver light output within the American Academy of Pediatrics recommended wavelength range (460–490 nm). Bench testing confirmed comparable light irradiance, thermal safety, and biocompatibility, with the SnugLit's larger treatment area and enhanced monitoring features providing refinements rather than fundamental differences in safety or effectiveness.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →